Advanced Practice Providers Oncology Summit.
2026 Oncology 102 Virtual Conference
October 22nd - 24th
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers
To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership
with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for
Advanced Practice Providers.” In this two-and-a-half-day virtual program, clinicians will gain a
greater understanding of cancer treatment, cancer therapies, side effects, supportive care
strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment
strategies for hematologic disorders and solid malignancies. Participation in the program will
allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide
APPs with a deeper understanding of the cancer treatment strategies they need to support and
care for cancer patients as part of the multidisciplinary oncology care team.
This program is appropriate for nurse practitioners, physician assistants, nurses, and
pharmacists in hematology/oncology seeking an in-depth review of cancer treatment strategies
and therapies.
*Students - Fellows
Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.
If you would like to attend as a Student, please contact info@horizoncme.com for further information.
**Industry Employee - See Registration Page for Pricing
**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Eastern Standard Time Zone
| Thursday, October 22, 2026 | |
|---|---|
| 11:00am | Welcome, Introductions, & CE Housekeeping |
| 11:15am | (01) Biomarker Testing: Understanding The How, Benefits, and Translating to Patient Care » TBA |
| 11:45am | (02) Patience and Understanding: Palliative Care for the APP » TBA |
| 12:45pm | Stump the Faculty – Panel Q&A Discussion |
| 1:00pm | Break |
| 1:15pm | (03) Pain Management: An Integral Component of Caring for the Oncology Patient » TBA |
| 2:15pm | (04) What is Chemotherapy? » TBA |
| 3:15pm | Stump the Faculty – Panel Q&A Discussion |
| 3:30pm | Break |
| 3:45pm | (05) Modern Management of Melanoma: Immunotherapy and Targeted Therapy in Focus » TBA |
| 4:15pm | (06) Survivorship » TBA |
| 4:45pm | (07) Deciphering Radiation Oncology: A Deeper Dive into Tumor-Specific Strategies and Technological Innovations » TBA |
| 5:45pm | Stump the Faculty – Panel Q&A Discussion |
| 6:00pm | Adjourn |
| Friday, October 23, 2026 | |
| 7:55am | Welcome, Introductions, & CE Housekeeping |
| 8:00am | (08) Neuro-Oncology for the APP: What is Going on Up There? » TBA |
| 8:30am | Stump the Faculty – Panel Q&A Discussion |
| 8:45am | (09) Deepening Clinical Practice in Breast Cancer Care » TBA |
| 9:45am | (10) Gastric Cancer: A Review of Current and Emerging Treatment Modalities » TBA |
| 10:15am | Stump the Faculty – Panel Q&A Discussion |
| 10:30am | Break |
| 10:45am | (11) Lung Cancer: Updates and Advancements » Beth Sandy, MSN, CRNP – Nurse Practitioner, Thoracic Medical Oncology | Abramson Cancer Center, University of Pennsylvania | Philadelphia, PA |
| 11:45am | (12) Current and Emerging Treatments for GU Malignancies: Prostate, Bladder, and RCC » TBA » TBA |
| 12:45pm | Stump the Faculty – Panel Q&A Discussion |
| 1:00pm | Lunch Break |
| 1:30pm | (13) Head and Neck Cancer: Diagnosis, Staging, and Management » TBA |
| 2:30pm | (14) Colorectal Cancer: Overview, Current Treatments, and Emerging Therapies » TBA |
| 3:30pm | Stump the Faculty – Panel Q&A Discussion |
| 3:45pm | Break |
| 4:00pm | (15) Multidisciplinary Management of Hepatocellular Carcinoma and Pancreatic Adenocarcinoma: Medical and Surgical Perspectives » TBA » TBA |
| 5:00pm | (16) Gynecologic Malignancies: Clinical Pearls » TBA |
| 5:30pm | Stump the Faculty – Panel Q&A Discussion |
| 5:45pm | Adjourn |
| Saturday, October 24, 2026 | |
| 7:55am | Welcome, Introductions, & CE Housekeeping |
| 8:00am | (17) A Deep Dive into Multiple Myeloma » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN – Nurse Practitioner | Department of Hematology and Medical Oncology | Cleveland Clinic | Cleveland, OH » TBA |
| 9:00am | Stump the Faculty – Panel Q&A Discussion |
| 12:45pm | Meet-the-Clinician Break |
| 9:15am | (18) Advances in CLL for the Clinical Oncology APP » TBA |
| 9:45am | (19) Advances in Follicular Lymphoma for the Clinical Oncology APP » TBA |
| 10:15am | Stump the Faculty – Panel Q&A Discussion |
| 10:30am | Break |
| 10:50am | (20) From Diagnosis to Treatment: Managing Acute Leukemia, MDS, and Myelofibrosis » TBA |
| 11:50am | Lunch Break |
| 12:20pm | (21) Emerging Therapies and Strategies in Classical Hematology: Bleeding and Thrombocytopenia » TBA » TBA |
| 1:35pm | (22) An Update of Current Treatment Options for Patients with Diffuse Large B-Cell Lymphoma » TBA |
| 2:35pm | (23) Cancer and Sexuality 102: Beyond the ‘What’ » TBA |
| 3:35pm | Stump the Faculty – Panel Q&A Discussion |
| 3:50pm | Adjourn |
Available Credit
- 21.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Live activity for a maximum of 21.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 21.75 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 21.75 credit.
Learning Objectives
Learning Objectives
- Describe the presentation, evaluation, and treatment of common, solid, and hematologic malignancies
- Recognize the presentation, evaluation, and treatment of common benign hematologic disorders
- Summarize the role of genetics and molecular testing in cancer care
- Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy
- Identify and appropriately manage common oncologic emergencies
- Outline the role of palliative care and effectively incorporate it into oncology practice
Intended Learners
This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.
Planning Committee

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN
Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic Cleveland, OH

Beth Sandy, MSN, CRNP
Nurse Practitioner Abramson Cancer Center, University of Pennsylvania Philadelphia, PA

Danielle Roberts, PA-C
APP Education Lead Co-Director Hematology/Oncology APP Fellowship Winship Cancer Institute, Emory University Atlanta, GA

Leigh Ann Childress, MSN, NP, AOCNP
Director of Advanced Practice Clearview Cancer Institute Huntsville, AL

Val R. Adams, PharmD, FCCP, FHOPA, BCOP
Associate Professor, University of Kentucky Oncology Specialist Markey Cancer Center Lexington, KY
